Collection of biological samples from patients with bone and growth plate disorders
Creation of a Biological Collection to Study the Pathophysiology and Identify Predictive Factors for the Evolution of Bone, Calcium and Growth Plate Pathologies
This study is collecting samples from children with bone and growth plate disorders to better understand their conditions and find new ways to help them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 350 (estimated) |
| Ages | N/A to 99 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT06444503 on ClinicalTrials.gov |
What this trial studies
This project aims to establish a comprehensive collection of biological and clinical data from children suffering from progressive bone, calcium, and growth plate pathologies. By gathering these samples, the study seeks to enhance the understanding of the mechanisms that lead to damage in growth plates and bones, as well as to identify predictive factors for disease progression and potential new therapeutic targets. The observational nature of the study allows for the collection of valuable data without direct intervention on the participants.
Who should consider this trial
Good fit: Ideal candidates for this study are children from birth with diagnosed growth plate or bone pathologies.
Not a fit: Patients under legal protection or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment options for children with bone and growth plate disorders.
How similar studies have performed: While this approach is observational and may not have direct precedents, similar studies in related fields have shown success in understanding complex bone disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children (from birth) with growth plate or bone pathology * Patients affiliated to or benefiting from a social security scheme * Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies : * mastery of the French language * Not being subject to a restriction of rights by the judicial authorities * Patients or legal representatives having given their consent to participate in the study (expression of non-opposition). Exclusion Criteria: * Patients under legal protection (guardianship, curatorship or safeguard of justice) * Pregnant or breast-feeding women
Where this trial is running
Toulouse
- University Toulouse Hospital — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Thomas EDOUARD, MD — University Hospital, Toulouse
- Study coordinator: Thomas EDOUARD, MD
- Email: edouard.t@chu-toulouse.fr
- Phone: 0534558555
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.